abstract |
The present invention establishes a simple and high sensitivity detection method for hEPR to provide a novel method for detecting human tumors expressing hEPR. Specifically, the present invention provides a monoclonal antibody that specifically recognizes human epiregulin (hEPR), a hybridoma producing the same, and a high sensitivity detection method of hEPR using the antibody. |